Preventing the next heart attack
AccuLine has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
AccuLine's investors include Mayo Clinic, Israel Innovation Authority, Google, eHealth Ventures, Mayo Clinic Ventures.
AccuLine is headquartered in Miami, United States.
Preventing the next heart attack
AccuLine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AccuLine — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/acculine. Accessed September 10, 2026.
VCBacked. (2024). AccuLine — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/acculine
{{cite web |title=AccuLine — Funding & Investors |url=https://www.vcbacked.co/company/acculine |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated